Navigation Links
deCODE Announces Positive Topline Results for Phase I Study of,DG051 for the Prevention of Heart Attack

REYKJAVIK, Iceland, May 01, 2007 /PRNewswire-FirstCall/ -- deCODE genetics today announced positive top-line results from its Phase I multiple dose clinical trial of DG051, which the company is developing for the prevention of heart attack. In the study, a randomized, double-blind, multi- dose, ascending dose, placebo-controlled clinical trial, a total of 40 healthy subjects were exposed to DG051 at doses up to 320mg per day for seven days. Building upon the positive results seen in the Phase I single dose study completed at the end of last year, key results were:

Safety and tolerability: DG051 was well tolerated at all dose levels tested, with no serious adverse events reported.

Dose-dependent reduction of leukotriene B4 (LTB4): DG051 was shown to reduce LTB4 production in a dose-dependent manner, with a peak reduction of more than 70% versus baseline after 7 days of treatment.

Pharmacokinetic profile: DG051 was found to have good bioavailability, with low variability between subjects. With a terminal half-life of approximately 9 hours and measurable concentrations at 24 hours after dosing, DG051 has a pharmacokinetic profile suitable for once-a-day dosing.

"The results of our Phase I trials show DG051 to be well tolerated and to provide a potent means of reining in the activity of the pathway our research has shown to modulate risk of heart attack. This latest study also provides us with pharmacodynamic data suggesting that we may be able to achieve a high steady-state reduction in LTB4 production with a dose in the middle of the range we have tested, and we look forward to entering DG051 into Phase II trials later this year," said Kari Stefansson, CEO of deCODE.

About DG051

DG051 is a first-in-class, small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H) discovered by deCODE's chemistry unit and being developed for the prevention of heart attack. LTA4H is encod
'"/>




Page: 1 2 3

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/25/2009)...,Nov.25/PRNewswire/--Reportlinker.comannouncesthat... ,, PainManagement-GlobalTrends ,, http...-Global-Trends.html ,, Widespreadavailabilityo...theadventofnewdrugshaveacceleratedthepaceofgrowthi...ursementstructurecontinuetoshapedemandforservices,...
(Date:11/24/2009)...A,Md.,Nov.24/PRNewswire-Asia/--ChindexInternationa...entAmericanproviderofWestern,healthcareproductsand...edthattheCompanywillattendthe21stAnnualPiperJaffra...1-2,2009,atthe,NewYorkPalaceHotel. , Manageme...y,December1,2009,andholdone-on-onemeetingsthrough...
(Date:11/24/2009)...O,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceutic...sentatthe21stAnnualPiperJaffrayHealthcareConferenc...).TheconferenceisbeingheldatTheNewYorkPalaceHotel....erofAnadys,willprovideanoverviewofAnadysanditsclin...corporatepresentationwillbesimultaneouslywebcastan...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Swine Flu Vaccine Seems Safe 3A Experts 56255 1Swine Flu Vaccine Seems Safe 3A Experts 56255 2Swine Flu Vaccine Seems Safe 3A Experts 56255 3Nurses and Retirement Security 3A A Looming Crisis 3F 56253 1Nurses and Retirement Security 3A A Looming Crisis 3F 56253 2Nurses and Retirement Security 3A A Looming Crisis 3F 56253 3Health Club Media Network Adds Crunch Health Club Chain 56249 1Health Club Media Network Adds Crunch Health Club Chain 56249 2
..., Jan. 6 The Michael J. Fox Foundation awarded a ...rch teams for pre-clinical research on potential n...nding was awarded under the Foundation,s Therapeu...launched in 2006, supports and bolsters industry-f...art of MJFF,s focus on ,de-risking, preclinical ...
...O, Jan. 5 Cylene Pharmaceuticals announced today ...its oral CK2 protein kinase inhibitor, CX-4945, in...disease, or multiple myeloma. The primary endpoint...ion of safety, tolerance and PK properties of CX-4...I trials. In addition, multiple mechanism-related ...
Other Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3
(Date:11/26/2009)...sequestering drug tetrathiomolybdate (TM) has been... of Wilson disease, a disease caused by an overloa...much is known. Very little, however, is known abou... new study led by Northwestern University research...-dimensional structure of TM bound to copper-loade...
(Date:11/26/2009)... No more letters from the North Pole, ...d text messages from Santa , ...ease operational efficiencies at the North Pole Sa...p children all over the globe informed of his Chri...ta’s research department have identified a l...
(Date:11/26/2009)... Benton Communications announces a hig...ystem for retailers struggling to make an economic...mber 26, 2009 -- Flu fears is the type of challeng...gency room, according to Dr. David Benton, busines...usiness growth system – The Rfactor Intensi...
(Date:11/25/2009)...SCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConvent...dicalcliniconDec.9-10,whenKansasCityhoststhelatest..., "Thisfreecliniceventhasthepotentialtobethebig...justoneandbeheldonweekdaysinsteadofoveraweekend,"S...hClinicandpresidentoftheNationalAssociationofFreeC...
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...pril 9, 2008 The Reproductive,Science Center of N...ditation Association for Ambulatory Health Care (A...Samuel Pang, medical director., Status as an accr...sion of quality health care, set by the,Accreditat...
...April 10 - May 6, SOUTHFIELD, Mich., April 9, 200...ed by WXYZ-TV/Channel 7, Astra Zeneca,Pharmaceutic...l be held,Thursday, April 10th through Tuesday, Ma...Clair, Washtenaw and Wayne.,Project Healthy Living...
...08 IC Sciences Corporation announced,today the es...ion of,Medical Information Sciences (DMIS), dedica... design and development of the burgeoning field of...he Division,s mandate also involves establishing t...
... the President Campaign Also to Air Bonus Special,... in August, NEW YORK, April 9, 2008 Nickelodeon,...itiative to build young citizens,awareness of the ... second of four specials, premiering Sunday, April...
..., April 9, 2008 Biological Psychiatry, in its upc... important commentary written by its Editors, memb...Board. This commentary is an urgent public statem...gators conducting research in non-human primates i...
... have no one to turn to for emotional support othe...aumatic situations, such as when suffering from ca...ners of cancer patients also often lack support ou...o few other people, if any. For 80 per cent of men...
Other Medicine News:Health News:Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation 2Health News:WXYZ-TV Announces 29th Annual Project Healthy Living 2Health News:IC Sciences Deepens Commitment to Pioneer Digital Informatics Instruments through New Medical Division 2Health News:IC Sciences Deepens Commitment to Pioneer Digital Informatics Instruments through New Medical Division 3Health News:Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee: Election Issues '08 Premiering Sunday, April 13, at 9:00 p.m. 2Health News:Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee: Election Issues '08 Premiering Sunday, April 13, at 9:00 p.m. 3Health News:Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee: Election Issues '08 Premiering Sunday, April 13, at 9:00 p.m. 4Health News:Attacks against medical researchers: Time to take a stand 2
Gimmi Yasargil Aneurysm-Vessel-Clips, fenestrated
Yasargil Phynox Aneurysm Clips Mini
Becker External Drainage and Monitoring System
Monitorr ICP External CSF Drainage System
Medicine Products: